Clinical Trial Update: Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

View source ↗

Summary

A clinical trial update describing cognitive aftereffects of neurotoxicity in children and young adults with relapsed/refractory hematologic malignancies treate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Leukemia | Status: RECRUITING